NO172394C - Antigent, syntetisk polypeptid, anvendelse derav til in vitro diagnose, vannopploeselig eller vanndisperbar antigen polymer, reseptormolekyl og diagnostisk proevesystem for bestemmelse av tilstedevaerelse av hbxag i en kroppsvaeske - Google Patents

Antigent, syntetisk polypeptid, anvendelse derav til in vitro diagnose, vannopploeselig eller vanndisperbar antigen polymer, reseptormolekyl og diagnostisk proevesystem for bestemmelse av tilstedevaerelse av hbxag i en kroppsvaeske

Info

Publication number
NO172394C
NO172394C NO85854448A NO854448A NO172394C NO 172394 C NO172394 C NO 172394C NO 85854448 A NO85854448 A NO 85854448A NO 854448 A NO854448 A NO 854448A NO 172394 C NO172394 C NO 172394C
Authority
NO
Norway
Prior art keywords
antigent
determination
diagnostic test
synthetic polypeptide
test systems
Prior art date
Application number
NO85854448A
Other languages
English (en)
Norwegian (no)
Other versions
NO854448L (no
NO172394B (no
Inventor
Ann M Moriarty
Hannah Alexander
Richard A Lerner
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of NO854448L publication Critical patent/NO854448L/no
Publication of NO172394B publication Critical patent/NO172394B/no
Publication of NO172394C publication Critical patent/NO172394C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/223—Hepatitis related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Transmission And Conversion Of Sensor Element Output (AREA)
  • Image Generation (AREA)
  • Editing Of Facsimile Originals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO85854448A 1984-03-08 1985-11-07 Antigent, syntetisk polypeptid, anvendelse derav til in vitro diagnose, vannopploeselig eller vanndisperbar antigen polymer, reseptormolekyl og diagnostisk proevesystem for bestemmelse av tilstedevaerelse av hbxag i en kroppsvaeske NO172394C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58757084A 1984-03-08 1984-03-08
US06/648,142 US4777240A (en) 1984-03-08 1984-09-07 SV40 expression vector containing HBxAg as an expression marker
PCT/US1985/000359 WO1985003950A1 (en) 1984-03-08 1985-03-06 A sv40 expression vector containing hbxag as an expression marker

Publications (3)

Publication Number Publication Date
NO854448L NO854448L (no) 1986-01-06
NO172394B NO172394B (no) 1993-04-05
NO172394C true NO172394C (no) 1993-07-14

Family

ID=27080076

Family Applications (1)

Application Number Title Priority Date Filing Date
NO85854448A NO172394C (no) 1984-03-08 1985-11-07 Antigent, syntetisk polypeptid, anvendelse derav til in vitro diagnose, vannopploeselig eller vanndisperbar antigen polymer, reseptormolekyl og diagnostisk proevesystem for bestemmelse av tilstedevaerelse av hbxag i en kroppsvaeske

Country Status (13)

Country Link
US (3) US4777240A (fi)
EP (1) EP0155147B1 (fi)
JP (1) JPH0832721B2 (fi)
AT (1) ATE59185T1 (fi)
AU (1) AU594642B2 (fi)
CA (1) CA1340732C (fi)
DE (1) DE3580927D1 (fi)
DK (1) DK175364B1 (fi)
FI (1) FI86585C (fi)
IL (1) IL74544A (fi)
NO (1) NO172394C (fi)
NZ (1) NZ211357A (fi)
WO (1) WO1985003950A1 (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4942125A (en) * 1984-09-07 1990-07-17 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
AU599348B2 (en) * 1985-12-18 1990-07-19 Microgenesys, Inc. Method for producing selected polypeptides in virally infected insect cells and polypeptides isolated therefrom
US4816564A (en) * 1986-01-31 1989-03-28 Merck & Co., Inc. Method for producing hepatitis B virus proteins in yeast
DE10299017I2 (de) * 1987-06-22 2005-05-25 Medeva Holdings Bv Hepatitis-B-Oberfl{chenantigen enthaltendes Peptid.
AU2913889A (en) * 1987-11-16 1989-06-14 Fox Chase Cancer Center Determination of anti-pol as an early marker of viral hepatitis infection
JPH0260589A (ja) * 1988-08-26 1990-03-01 Natl Sci Council バクテリオファージｍ１３の遺伝子□ｄ２プロモーターを使用した大腸菌中での外来タンパクの高レベル産生
US5650275A (en) * 1990-06-11 1997-07-22 Nexstar Pharmacueticals Inc Target detection method using spectroscopically detectable nucleic acid ligands
EP0491077A1 (en) * 1990-12-19 1992-06-24 Medeva Holdings B.V. A composition used as a therapeutic agent against chronic viral hepatic diseases
US6297048B1 (en) * 1992-02-04 2001-10-02 Chiron Corporation Hepatitis therapeutics
US5378605A (en) * 1993-06-08 1995-01-03 Thomas Jefferson University Method of detecting hepatitis B variants having deletions within the X region of the virus genome
US5872206A (en) * 1994-10-06 1999-02-16 The General Hospital Corporation Compositions and methods for interfering wtih hepatitis B virus infection
EP1049711B1 (en) * 1998-01-19 2003-12-10 Mogam Biotechnology Research Institute Liposomes comprising peptide antigens derived from x protein of hepatitis b virus
WO1999039200A1 (en) * 1998-01-29 1999-08-05 Thomas Jefferson University Molecular markers for diagnosing hepatocellular carcinoma
US6638903B2 (en) 2002-01-15 2003-10-28 Milliken & Company Non-staining red colorants and liquid fabric softener formulations comprising such non-staining colorants
US6593289B1 (en) 2002-01-15 2003-07-15 Milliken & Co. Liquid fabric softener formulations comprising hemicyanine red colorants
EP1774625B1 (en) 2004-07-13 2014-06-25 Panduit Corporation Communications connector with flexible printed circuit board
EP2390967B1 (en) 2005-07-15 2013-02-13 Panduit Corporation Communications connector with crimped contacts
WO2007110098A1 (en) * 2006-03-29 2007-10-04 Institut National De La Sante Et De La Recherche Medicale HBx PEPTIDES, CAPABLE OF ELICITING A PROMISCUOUS IMMUNODOMINANT CD4+ RESPONSE DIRECTED AGAINST HBV
NZ586074A (en) * 2010-06-10 2013-07-26 Auckland Uniservices Ltd LCLRP peptides, constructs and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (nl) * 1971-02-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen.
US4415491A (en) * 1980-01-14 1983-11-15 The Regents Of The University Of California Synthetic vaccine peptide epitomes of hepatitis B surface antigen
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
FI83662C (fi) * 1980-07-17 1991-08-12 Scripps Clinic Res Diagnostik antikropp och foerfarande foer dess framstaellning.
ZW18282A1 (en) * 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
US4442205A (en) * 1981-09-22 1984-04-10 The United States Of America As Represented By The Department Of Health And Human Services Simian virus recombinant that directs the synthesis of hepatitis B surface antigen
US4459359A (en) * 1981-11-19 1984-07-10 New York Blood Center, Inc. Sensitive immunoassays of antigens or antibodies sequestered within immune complexes
JPS5936698A (ja) * 1982-08-20 1984-02-28 Science & Tech Agency Ｂ型肝炎ウイルス遺伝子を組込んだ組換えｄｎａおよび形質転換動物細胞
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4942125A (en) * 1984-09-07 1990-07-17 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen

Also Published As

Publication number Publication date
JPH0832721B2 (ja) 1996-03-29
NO854448L (no) 1986-01-06
US5183734A (en) 1993-02-02
IL74544A (en) 1994-11-11
JPS61502094A (ja) 1986-09-25
NO172394B (no) 1993-04-05
DK175364B1 (da) 2004-09-13
US4777240A (en) 1988-10-11
ATE59185T1 (de) 1991-01-15
AU594642B2 (en) 1990-03-15
WO1985003950A1 (en) 1985-09-12
FI854395A0 (fi) 1985-11-07
IL74544A0 (en) 1985-06-30
AU4067285A (en) 1985-09-24
DK516585D0 (da) 1985-11-08
DE3580927D1 (de) 1991-01-31
EP0155147A2 (en) 1985-09-18
CA1340732C (en) 1999-09-14
EP0155147B1 (en) 1990-12-19
FI86585C (fi) 1992-09-10
FI854395A (fi) 1985-11-07
NZ211357A (en) 1988-08-30
EP0155147A3 (en) 1985-11-06
DK516585A (da) 1985-11-08
FI86585B (fi) 1992-05-29
US5534405A (en) 1996-07-09

Similar Documents

Publication Publication Date Title
NO172394C (no) Antigent, syntetisk polypeptid, anvendelse derav til in vitro diagnose, vannopploeselig eller vanndisperbar antigen polymer, reseptormolekyl og diagnostisk proevesystem for bestemmelse av tilstedevaerelse av hbxag i en kroppsvaeske
DK2289A (da) Monoklonale antistoffer samt deres fremstilling og anvendelse
SE9500023L (sv) Sätt att detektera cancer
DK0687295T3 (da) Human B-lymfoblastoidcellelinje, der secernerer anti-gangliosid-antistof
ATE122148T1 (de) Menschliche gamma, delta-t-zellen-antigen- rezeptor-polypeptide und nukleinsäuren.
NO177463C (no) STLV-III-beslektede polypeptider, diagnostiske prövesett og in vitro analysefremgangsmåte for påvisning av anti-HIV-2-antistoffer i kroppsvæskepröve
GR3015284T3 (en) Human macrophage inflammatory protein 2-beta.
ATE93629T1 (de) Verfahren zur diagnose in vitro von menschlichen cytomegalovirusinfektionen und anwendung von monoklonalen antikoerpern gegen cytomegaloviren, die mit einer cytomegalovirusinduzierten proteinkinase reagieren.
ES8802196A1 (es) Metodo para determinar la presion de un estado maligno en tejidos.
DK414386D0 (da) Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse
Kozlowska et al. Use of the macrophage migration inhibition test to evaluate antigenic differences in golden hamster transplantable melanomas
IT1057062B (it) Cartina di prova per la rivelazione del glucosio e galattosio..particolarmente nelle urine
ATE15944T1 (de) Diagnoseverfahren.
Nash et al. Anergy in active pulmonary tuberculosis
Tsuang et al. Lack of effect of schizophrenic sera on growth of human HeLa cells.
Bakulin et al. Method for the preparation of erythrocytic diagnostic reagent for detecting type A Clostridium perfringens enterotoxin.
Muizhnek Method of Corrosion Cracking Testing on an" ALA-TOO" Instrument
Borek Monoclonal antibodies and cancer therapy: Reisfeld, RA and Sell, S.(Eds.), 632 pp. Alan R. Liss, New York, 1985, $78.00, ISBN 0-8451-2626-1
Borek Defined Immunofluorescence and Related Cytochemical Methods: edited by EH Beutner, RJ Nisengard and B. Albini. The New York Academy of Sciences, New York, 1983 (Ann. NY Acad. Sci., Vol. 420, 432 pp., illus.) $84.00
NO177310C (no) Antigent polypeptid fra HBxAg, antistoff som reagerer med polypeptidet, diagnostisk analysesystem for bestemmelse av tilstedeværelsen av HBxAg i en kroppspröve, samt anvendelse av polypeptidet til in vitro diagnose
NO921879L (no) Fremgangsmaate til maaling av t-celleoverflateantigener i mennesker

Legal Events

Date Code Title Description
MK1K Patent expired